Aumann AG

AAG.DE Q3 2025

Reported: 2025-11-13

Aumann AG's Q3 2025 results reveal a significant 32% revenue decline year-over-year, primarily driven by a weaker order intake amidst challenging market conditions; however, the company managed to maintain a solid EBITDA margin of 11.6%.

Key takeaways

Revenue for the first nine months totaled EUR 158 million, impacted by cautious investment behaviors across the automotive sector.
Aumann remains a technology leader in E-mobility, with robust growth in battery module solutions and modular production systems.
Strategic initiatives are now focused on expanding the Next Automation segment into industries such as aerospace, life sciences, and cleantech, leveraging existing capabilities in electric motors and system integration.

View recap

Absci Corporation Common Stock

ABSI Q3 2025

Reported: 2025-11-13

Absci Corporation's Q3 2025 update highlights pivotal advancements in its drug pipeline, particularly for ABS-201, which is positioned for dual clinical trials in androgenetic alopecia and endometriosis. The operational focus shift underscores the company’s commitment to maximizing shareholder value through strategic resource allocation.

Key takeaways

Interim results from the ABS-101 phase one trial demonstrated favorable safety and extended half-life compared to competitor programs, but development will be halted post-trial as resources are shifted to ABS-201.
ABS-201 is on track to initiate a phase 1/2a trial for androgenetic alopecia by December 2025, with an interim readout expected in 2026.
The company is expanding ABS-201's development into endometriosis, planning a phase two trial in 2026, which could address a significant unmet need in women's health.
Dual development of ABS-201 targets a multibillion-dollar market opportunity, leveraging shared trial resources for potential high-value outcomes.
A KOL seminar is scheduled for December 11, 2025, to discuss ABS-201’s market potential and further supporting data, illustrating the company’s proactive engagement with the medical community.

View recap

Alcon Inc.

ALC Q3 2025

Reported: 2025-11-13

Alcon's third-quarter 2025 results demonstrate solid progress, highlighted by strong growth in surgical equipment and contact lenses, while continuing to innovate in ocular health solutions.

Key takeaways

Surgical equipment sales exhibit robust momentum, driven by successful Unity VCS and upcoming Unity CS launches, enhancing efficiency in cataract procedures.
PanOptix Pro is stabilizing market share in the U.S. Trifocal IOL category, with significant advancement in optical design leading to improved patient outcomes.
Contact lens segment shows double-digit growth in toric modalities, expanding access for astigmatic patients and capturing a significant market opportunity.
The Systane artificial tears brand continues to gain traction, aided by the successful launch of preservative-free formulations and Tryptyr for dry eye treatment, enhancing patient convenience and experience.
Alcon's commitment to innovation is underscored by strong performance at major ophthalmic conferences, supporting its competitive positioning in the eye care market.

View recap

Bayer Aktiengesellschaft

BAYRY Q3 2025

Reported: 2025-11-13

The company reported mixed third-quarter results for 2025, with core EPS up 7% year-over-year while free cash flow remained negative, largely driven by seasonal factors and ongoing regulatory challenges.

Key takeaways

Crop Science showed resilience with corn sales up 9% year-to-date, despite Q3 being typically weaker for the agriculture sector.
Pharmaceuticals delivered strong performance, particularly with Nubeqa and Kerendia, which saw year-over-year growth of 60% and 80%, respectively.
Consumer Health is facing a challenging market environment, prompting a downward revision of full-year sales expectations.
Management remains confident in achieving 2025 guidance amid ongoing litigation challenges and regulatory pressures.
The FDA approval of Lynkuet and positive data from the Kerendia study present growth opportunities beyond 2025.

View recap

Better Home & Finance Holding Company Class A Common Stock

BETR Q3 2025

Reported: 2025-11-13

Better Home & Finance Holding Company reported a pivotal Q3 2025, highlighting a transformative shift toward an AI-driven platform that enhances profitability and market reach through strategic partnerships.

Key takeaways

Announced three new partnerships that validate the company's strategy and are expected to significantly expand market reach.
Monthly funded loan volume is projected to double to at least $1 billion within six months, driven by strong momentum from partnerships.
Achieving breakeven adjusted EBITDA by Q3 2026 remains a key goal, supported by the strong unit economics of the Tinman AI platform.
Default rates for originated mortgages are one-third that of the industry average, showcasing the effectiveness of Better's proprietary data and AI models.
Continued expansion of the client pipeline illustrates growing demand for Better's innovative solutions in the home finance space.

View recap

Bilibili Inc.

BILI Q3 2025

Reported: 2025-11-13

Solid growth and improved profitability were key highlights for Bilibili in Q3 2025, as the company leveraged its engaged community and quality content to enhance commercial value.

Key takeaways

Daily active users (DAUs) reached 117 million, up 9% year over year, while monthly active users (MAUs) grew 8% to 376 million.
Total net revenues increased 5% year over year to RMB 7.7 billion, with gross profit rising 11% and gross margin expanding to 36.7%.
Non-GAAP net profit surged 233% year over year, reflecting successful cost management and a shift toward higher-margin revenue streams.
Monthly paying users rose 17% year over year to a record 35 million, driven by increased engagement with gaming and value-added services.
The launch of the successful game "Escape from Duckhoff, Haori Yakufu" reinforces Bilibili's capabilities in game development, catering to a growing market demand.

View recap

Bitfarms Ltd.

BITF Q3 2025

Reported: 2025-11-13

Bitfarms delivered robust growth in Q3 2025, advancing its strategic transition towards becoming a leader in high-performance computing (HPC) and AI infrastructure, capitalizing on increasing demand and higher lease rates in the data center sector.

Key takeaways

Revenue growth driven by increased demand for HPC and AI infrastructure, with lease rates rising significantly from $120 to $150 per kilowatt per month.
Continued investments in energy and infrastructure position Bitfarms to capture the anticipated shortfall of 45 gigawatts of power for data centers by 2030.
Strategic focus on long-term, high-value contracts to optimize margins, prioritizing infrastructure development to reduce time between lease signing and revenue generation.

View recap

Bitfarms Ltd.

BITF.TO Q3 2025

Reported: 2025-11-13

Bitfarms delivered solid growth in Q3 2025, emphasizing its transition to a key player in high-performance computing (HPC) and artificial intelligence (AI) infrastructure. The company is well-positioned to capitalize on escalating demand amid significant infrastructure bottlenecks.

Key takeaways

Fundamental shift towards HPC and AI is driving demand for data center capacity, with lease rates increasing from an average of 3% to 12% since 2022.
Bitfarms aims to optimize revenue through strategic infrastructure development, focusing on minimizing time to revenue and securing higher lease rates with long-term agreements.
Anticipating a critical shortfall of 45 gigawatts of power for data centers by 2030, the company is preparing to leverage its energy and infrastructure ownership to enhance profitability.
Investment strategy includes pioneering infrastructure for next-gen NVIDIA Vera Rubin GPUs, distinguishing Bitfarms from competitors by addressing future demands in the GPU market.

View recap

Bitcoin Depot Inc. Class A Common Stock

BTM Q3 2025

Reported: 2025-11-13

Bitcoin Depot delivered a robust third quarter in 2025, achieving a 20% revenue growth driven by increased kiosk deployment and strong consumer demand, while also improving profitability and cash flow.

Key takeaways

Revenue reached $162.5 million, supported by a 40% increase in median transaction size and enhanced kiosk optimization efforts.
Adjusted EBITDA surged 75% to $16.1 million, reflecting effective cost management and operational leverage.
The company expanded its kiosk network to approximately 9,300 active machines and completed the acquisition of over 500 additional kiosks, reinforcing its market leadership in North America.
Implemented stringent compliance standards to enhance consumer protection, positioning Bitcoin Depot favorably against regulatory changes in the industry.
With over $70 million in cash and digital assets, Bitcoin Depot remains well-equipped to pursue strategic growth opportunities and accretive acquisitions.

View recap

Broadwind, Inc.

BWEN Q3 2025

Reported: 2025-11-13

Broadwind, Inc. reported strong performance in Q3 2025, achieving a 25% revenue increase year-over-year, driven by robust demand across power generation and renewable markets. The company also bolstered its strategic position through a significant consolidation of operations.

Key takeaways

Third-quarter consolidated revenues reached $44.2 million, up 25% year-over-year, propelled by strong heavy fabrication and Industrial Solutions segments.
Orders surged 90% year-over-year, hitting $44 million, bolstered by a doubling of orders from power generation customers.
Completed the $8.2 million sale of the Manitowoc facility, enhancing operational efficiency and asset utilization at the remaining Texas facility.
Announced a $3 million share repurchase program, reflecting confidence in long-term value and future growth prospects.
Adjusted EBITDA declined to $3.4 million, primarily due to temporary production inefficiencies and lower capacity utilization within the Gearing segment.

View recap

Beyond Meat, Inc.

BYND Q3 2025

Reported: 2025-11-13

Beyond Meat reported a challenging Q3 2025 with a 13.3% year-over-year decline in revenue, though significant strides were made to restructure the balance sheet by reducing debt by approximately $900 million.

Key takeaways

Net revenue of $70.2 million, down 13.3% year-over-year, within guided range but indicative of ongoing category challenges.
Gross margin decreased to 10.3% from 17.7% as higher trade promotions and lower volumes pressured financials.
Completed a significant balance sheet restructuring, reducing total debt by nearly 75%, with a path to further reductions of over 90%.
Focused on addressing misinformation about plant-based products while introducing new offerings aimed at improving taste and nutritional profiles.
Operational improvements noted, with operating expenses declining sequentially despite substantial nonroutine costs.

View recap

Crescent Capital BDC, Inc.

CCAP Q3 2025

Reported: 2025-11-13

Crescent Capital BDC reported steady net investment income of $0.46 per share for Q3 2025, maintaining a strong dividend coverage of 110%, despite challenges from the macroeconomic environment.

Key takeaways

Net asset value decreased to $19.28 per share, primarily due to portfolio losses linked to tariff impacts.
Continued robust diversification with $1.6 billion invested across 187 companies; 90% in first lien loans.
Fourth-quarter dividend declared at $0.42 per share, reflecting a strong 9.12% annualized yield.
Anticipated opportunities from reduced base rates may bolster new deal activity and fee income.
Spillover income of approximately $1.1 per share offers a buffer against potential earnings pressure.

View recap

Central Puerto S.A.

CEPU Q3 2025

Reported: 2025-11-13

Central Puerto delivered a robust performance in Q3 2025, with adjusted EBITDA reaching $101.1 million, reflecting strong operational gains and strategic advancements in renewable energy and thermal generation.

Key takeaways

Adjusted EBITDA increased 64% quarter-on-quarter and 8% year-on-year, supported by higher revenues from contract sales in renewables and thermal sectors.
Revenues climbed to $233.9 million, up 30% quarter-on-quarter, bolstered by successful fuel cost pass-through mechanisms.
The company secured two Battery Energy Storage System projects totaling 205 megawatt-hours, enhancing its growth strategy and operational capabilities.
Capital expenditures for Q3 totaled $76.1 million, including the acquisition of Cafayate solar farm, and key projects nearing completion will further enhance capacity.
A new regulatory framework aimed at liberalizing the Argentine electricity market is expected to provide additional revenue opportunities and mitigate risks for generators.

View recap

Chemtrade Logistics Income Fund

CHE-UN.TO Q3 2025

Reported: 2025-11-13

Chemtrade Logistics Income Fund reported record adjusted EBITDA and strong revenue growth in Q3 2025, driven by effective operational strategies and a diversified product mix.

Key takeaways

Achieved the highest quarterly EBITDA in company history, with a 10% year-over-year increase.
Revenue rose by 12%, with the Sulphur and Water Chemicals segment showing a significant 19% growth.
Distributable cash after maintenance CapEx surged 18%, translating to a 24% increase on a per unit basis.
Maintained a strong balance sheet with a net debt-to-EBITDA ratio of 1.8x and ample liquidity of approximately USD 484 million.
Raised full year 2025 adjusted EBITDA guidance on favorable market conditions, anticipating record performance surpassing previous years.

View recap

CI&T Inc

CINT Q3 2025

Reported: 2025-11-13

CI&T Inc delivered strong Q3 2025 results, achieving record revenues of $127.3 million with 12.1% organic growth while effectively positioning itself as a leader in AI-driven business solutions.

Key takeaways

Revenue grew 12.1% organically year-over-year, surpassing guidance, and 13.4% on a reported basis.
Adjusted EBITDA margin stood at 18.5%, reflecting healthy profitability amidst robust growth.
CI&T Flow, the company's AI management platform, is bridging the gap between AI investment and tangible business results for clients.
The company secured high-profile partnerships, demonstrating the effectiveness of its AI solutions in improving operational efficiencies across various sectors.
CI&T Inc is well-positioned to address the growing demand for AI transformation services, capitalizing on the industry's challenges in delivering measurable results.

View recap

Cellebrite DI Ltd. Ordinary Shares

CLBT Q3 2025

Reported: 2025-11-13

Cellebrite DI Ltd. reported robust third-quarter results for 2025, highlighted by strong growth in annual recurring revenue (ARR) and subscription sales, reflecting solid demand across key segments.

Key takeaways

ARR grew by 19% year-over-year, with subscription revenue rising 21%, driven by strong performance in the U.S. state and local sectors.
Adjusted EBITDA increased by 20%, accompanied by a 60 basis points margin expansion, underscoring efficiency improvements alongside revenue growth.
The company successfully converted approximately 47% of its installed digital forensics license base to the insights offering, on target to surpass its 2025 goal.
Cloud and SaaS solutions are gaining traction, with ARR for these offerings growing three times faster than total ARR, doubling the customer base for the Guardian solution year-over-year.
Strategic investments in the defense and intelligence sector are proving fruitful, with increased adoption by global agencies for critical use cases.

View recap

ClearPoint Neuro, Inc.

CLPT Q3 2025

Reported: 2025-11-13

ClearPoint Neuro reported a solid Q3 with revenue growth of 9% year-over-year, while announcing a strategic merger with IRRAS that is set to expand their market reach and operational scale.

Key takeaways

Q3 2025 revenue reached $8.9 million, up from $8.1 million in Q3 2024, demonstrating continued growth momentum.
The merger with IRRAS is anticipated to create a new $10 billion market opportunity in neuro drug delivery and enhance operational capabilities with an expanded sales team.
ClearPoint anticipates significant synergies from the consolidation, including immediate market access to a $0.5 billion segment through the IRRAflow catheter.
The company secured an additional $20 million in funding to support merger integration and new growth initiatives following the acquisition.
Strategic plans emphasize launching innovative products within existing segments while building a robust ecosystem for drug delivery in partnership with biopharma entities.

View recap

Canadian Solar Inc.

CSIQ Q3 2025

Reported: 2025-11-13

Canadian Solar reported strong Q3 2025 results with revenues of $1.5 billion, driven by record energy storage shipments and a resilient North American market performance despite ongoing macroeconomic challenges.

Key takeaways

Delivered 5.01 GW of solar modules and achieved record energy storage shipments of 2.7 GWh.
Gross margin improved to 17.2%, exceeding guidance due to increased contributions from energy storage.
Net income attributable to shareholders was $9 million, or a net loss of $0.07 per diluted share, affected by preferred share obligations.
U.S. manufacturing investments are advancing, with solar cell production expected to start in Indiana and energy storage manufacture in Kentucky by late 2026.
Residential energy storage is on track for profitability in 2025, expanding market presence in Japan, Italy, the U.S., and entering Germany and Australia.

View recap

CuriosityStream Inc.

CURI Q3 2025

Reported: 2025-11-13

CuriosityStream reported robust Q3 2025 results, with a 46% year-over-year revenue increase to $18.4 million and substantial growth in adjusted free cash flow, reflecting strong momentum across its key business pillars.

Key takeaways

Revenue reached $18.4 million, exceeding guidance and representing a 46% increase from Q3 2024.
Adjusted free cash flow surged 88% year-over-year to $4.8 million, marking seven consecutive quarters of positive cash flow.
Content licensing revenue skyrocketed over 425% to $8.7 million, driven by demand for AI training data and strong partnerships.
Sequential growth in subscription revenue has been consistent throughout 2025, indicating operational improvements rather than just price increases.
The company aims to double or triple its roster of AI licensing partners by 2026, anticipating continued robust growth across all revenue streams.

View recap

CXApp Inc. Class A Common Stock

CXAI Q3 2025

Reported: 2025-11-13

CX AI delivered a strong performance in Q3 2025, marked by significant advancements in its AI-driven workplace solutions and increased market validation.

Key takeaways

Gartner recognized CX AI as a representative vendor in the 2025 market guide for workplace experience applications, reinforcing its innovative position.
The company operates in over 200 cities, serving more than a million users with integrated, AI-enhanced workplace solutions.
Strategic partnerships, including collaboration with Noro, are positioned to enhance CX AI’s capabilities in the rapidly evolving AI landscape.
Increased presence at major tech events underscored the urgency of AI adoption in workplace environments, highlighting CX AI’s role in bridging operational gaps.
Continuous investment in R&D, with over 70% of staff focused on innovation, supports the company's commitment to technology-driven productivity solutions.

View recap

The Walt Disney Company

DIS Q4 2025

Reported: 2025-11-13

Strong earnings growth in Q4 2025 was driven by successful film releases and significant progress in direct-to-consumer services, as Disney continues to enhance its strategic focus on core assets.

Key takeaways

Adjusted EPS rose 19% year-over-year, maintaining a 19% compound annual growth rate over the last three years.
Share repurchase target for 2026 is set at $7 billion, doubling the previous year, alongside a 50% increase in the cash dividend to $1.50 per share.
The DTC segment saw a substantial turnaround, posting a 39% operating income increase in Q4, reaching $1.3 billion for the full year.
Disney Studios achieved record box office numbers with major releases, including the highest-grossing Hollywood film of the year, "Lilo and Stitch."
ESPN launched a full direct-to-consumer service with positive early fan engagement, enhancing the viewing experience across its platforms.

View recap

Dream Unlimited Corp.

DRM.TO Q3 2025

Reported: 2025-11-13

Dream Unlimited Corp. reported a strong third quarter with net earnings of $27.4 million, a notable increase from $9.8 million in the previous year, driven by solid performance across its core operating business.

Key takeaways

Net margin reached $24.1 million, showcasing robust growth from last year's $9.8 million.
Asset Management division saw revenue of $14.5 million and a net margin of $11 million, reflecting steady base growth.
Western Canada Development generated $61.6 million in revenue with 137 lot sales, primarily driven by strong activity in Calgary's Alpine Park.
Management remains optimistic about the economic outlook, citing potential for growth from major projects and strategic positioning despite broader economic uncertainties.

View recap

Deutsche Telekom AG

DTE.DE Q3 2025

Reported: 2025-11-13

Deutsche Telekom delivered solid financial results in Q3 2025, marked by a 3.7% organic revenue growth and a proposed 11% dividend increase, confirming its robust long-term strategic positioning.

Key takeaways

Achieved 3.7% organic service revenue growth and 9.5% adjusted earnings per share growth year-to-date.
Raised full-year guidance in response to T-Mobile's improved performance, with a focus on disciplined financial execution.
Proposed an 11% increase in dividend to EUR 1 per share and a EUR 2 billion share buyback plan for 2026, totaling nearly EUR 7 billion in shareholder returns.
Continued strong progress in fiber expansion, passing 3.6 million homes in Europe and solidifying leadership in both U.S. and European markets.
Launched Europe’s first industrial AI cloud in partnership with NVIDIA, further driving digital transformation initiatives.

View recap

Durr Aktiengesellschaft

DUE.DE Q3 2025

Reported: 2025-11-13

Dürr demonstrated strong profitability in Q3 2025, with EBIT margin reaching 6.6%, reflecting solid earnings growth across all divisions despite ongoing macroeconomic challenges.

Key takeaways

EBIT margin before extraordinary items improved to 6.6%, almost 2 percentage points higher than last year.
Free cash flow remained robust, totaling EUR 85 million year-to-date, supporting ongoing operational stability.
The company confirmed its full-year guidance, expecting improved sales traction in Q4 driven by accelerated project execution in the Automotive division.
Despite a 29% decline in year-to-date order intake, the outlook for large orders in Q4 remains optimistic, particularly in the automotive and timber house construction sectors.

View recap

Eagle Point Credit Company Inc.

ECC Q3 2025

Reported: 2025-11-13

Eagle Point Credit Company reported a GAAP net income of $16 million for Q3 2025, showcasing strategic portfolio management despite a decline in cash flows and NAV.

Key takeaways

Deployed nearly $200 million into new investments with a weighted average yield of 16.9% in CLO equity.
Recurring cash flows fell to $77 million, or 59¢ per share, down from $85 million in Q2.
NAV decreased to $7 per share, a 4.2% drop from the previous quarter, while the company's WARP remained significantly above market average at 3.4 years.
Paid regular monthly distributions of 14¢ per share to common shareholders, maintaining a disciplined return strategy.
Continued focus on portfolio optimization and refinancing efforts aims to enhance future cash flow stability.

View recap

Eagle Point Income Company Inc.

EIC Q3 2025

Reported: 2025-11-13

Eagle Point Income Company reported a positive third quarter for 2025 with an increase in NAV and solid coverage for its distribution, despite challenges from recent Fed rate cuts.

Key takeaways

NAV rose to $14.21 per share, up from $14.08, reflecting strong portfolio performance and disciplined capital management.
Generated net investment income of $0.26 per share, consisting of $0.39 net investment income offset by $0.13 in realized capital losses.
Issued $35 million of preferred stock and repurchased $21 million of common stock, enhancing shareholder value and resulting in $0.11 per share of NAV accretion.
Monthly distribution decreased to $0.11 per share due to lower earnings expectations from Fed rate cuts, aligned with the company's outlook.
The company remains committed to aggressive share repurchases, increasing its authorization to $60 million to capitalize on stock trading at a discount to NAV.

View recap

Fortress Biotech, Inc.

FBIO Q3 2025

Reported: 2025-11-13

Journey Medical delivered robust performance in Q3 2025, achieving 21% year-over-year revenue growth, driven primarily by the strong uptake of its new oral treatment, EMROSI.

Key takeaways

EMROSI contributed $4.9 million, showing a 75% revenue increase compared to Q2, with total prescriptions growing 146%.
Despite a 16% year-over-year decline in revenue for legacy products due to Accutane generic competition, overall product revenues grew by more than 16% year-over-year.
Operating expenses rose only 9%, highlighting effective expense management linked to EMROSI's launch and potential for sustainable EBITDA positivity in Q4.
Over 2,700 unique prescribers have adopted EMROSI, a 50% increase since the last earnings call, indicating strong market acceptance and growth potential.
The company has secured access for EMROSI across over 100 million of the 187 million commercial lives, with further GPO contracting expected.

View recap

FLEX LNG Ltd.

FLNG Q3 2025

Reported: 2025-11-13

Flex LNG reported strong third-quarter results, achieving net income of $16.8 million and maintaining a robust cash balance of $479 million, despite challenges in the spot market.

Key takeaways

Revenues of $85.7 million and a time charter equivalent of $70,900 per day, demonstrating resilience despite a softer LNG market.
Adjusted net income increased to $23.5 million ($0.43 EPS), reflecting effective cost management and refinancing benefits.
Maintained a substantial cash position with no debt maturities until 2029 and declared a consistent dividend of $0.75 per share, yielding 11%.
Strong contract backlog of 53 years, with the potential for growth to 80 years if options are exercised, ensuring revenue stability.
Successfully completed critical dry dockings for multiple vessels, enhancing operational reliability and readiness for future opportunities.

View recap

Flutter Entertainment plc

FLUT Q3 2025

Reported: 2025-11-13

Flutter Entertainment's Q3 2025 results showed robust revenue growth of 17% year-over-year, driven by strong consumer engagement, despite a reported net loss due to non-cash items. The company is strategically expanding into prediction markets with the upcoming launch of FanDuel Predicts.

Key takeaways

Average monthly players exceeded 14 million, highlighting strong customer engagement across platforms.
Revenue growth of 17% year-over-year, with a 44% increase in iGaming performance, showcases strong market positioning.
Adjusted EBITDA guidance revised down by $280 million for 2025 due to regulatory challenges and competitive dynamics impacting sports betting.
FanDuel is set to launch a new product in December to capture the prediction markets opportunity, with robust support from a strategic partnership with CME Group.
Strong market share retention in iGaming and sportsbook, maintaining a 47% share amid a highly competitive environment.

View recap

Fly Leasing Limited

FLY Q3 2025

Reported: 2025-11-13

Firefly Aerospace reported a robust third quarter with a significant $1.3 billion backlog, bolstered by its recent acquisition of SciTech, despite a setback involving its Alpha rocket program.

Key takeaways

Achieved a backlog of $1.3 billion at the end of Q3, reflecting strong demand across multiple product lines.
Closed the acquisition of SciTech, enhancing Firefly's software capabilities for defense and space applications.
Experienced a ground test setback with the Alpha rocket due to a contamination issue, leading to the loss of a first-stage booster; corrective measures have been implemented to prevent recurrence.
Positioned strategically to capitalize on increased defense funding and emerging opportunities in the space sector, including AI and lunar missions.
Ongoing upgrades to the Alpha stage test stand are expected to enhance operational reliability ahead of the next launch window.

View recap

Fiera Capital Corporation

FSZ.TO Q3 2025

Reported: 2025-11-13

Fiera Capital reported a strong third quarter for 2025, with total assets under management rising 4% to $166.9 billion, driven by market appreciation and significant net organic growth. The private market platform experienced robust inflows, underscoring the company's strong positioning in both public and private investment strategies.

Key takeaways

Total assets under management increased to $166.9 billion, with public market AUM at $145 billion and private market AUM at $22 billion.
Net organic growth in private markets was notably strong at approximately $850 million, driven by new subscriptions including an initial $800 million from the Canadian Built Opportunities Fund.
Fiera Capital was awarded Fixed Income Manager of the Year at the 2025 European Awards, reflecting the strong performance and expertise of its fixed income strategies.
Despite positive returns in its equity strategies, performance relative to benchmark was mixed due to security selection challenges in key sectors.
The company deployed approximately $400 million into new projects in Q3 and returned $150 million in capital to private market investors, showing a strong commitment to liquidity and growth.

View recap

Fathom Holdings Inc.

FTHM Q3 2025

Reported: 2025-11-13

Fathom Holdings reported a robust 37.7% year-over-year revenue growth for Q3 2025, significantly surpassing analyst expectations, and achieved continued profitability in adjusted EBITDA, reflecting the strength of its operational strategy and agent-centric model.

Key takeaways

Revenue growth nearly doubled analyst estimates, with robust performance across core brokerage and ancillary segments.
Agency base expanded by 24% year-over-year to over 15,300 agents, with a notably low turnover rate of 1% monthly.
Gross profit increased by over $2.7 million, with more than 50% contributing directly to EBITDA, demonstrating effective expense management.
Strong momentum observed in ancillary businesses, with mortgage revenues up 20.7% and title revenues increasing 28.6%, supporting margin expansion.
Growth in file starts for mortgage and title services soared over 60% year-over-year, indicating strong demand and integration of services within the real estate network.

View recap

Assicurazioni Generali S.p.A.

G.MI Q3 2025

Reported: 2025-11-13

Generali Group delivered robust growth in its P&C segment and maintained strong margins in Q3 2025, confirming progress on its Lifetime Partner 27 strategy amidst an evolving market.

Key takeaways

P&C top line increased by over 7% year-to-date, with an undiscounted combined ratio improving by more than 2 percentage points.
Life net inflows surpassed €10 billion, driven by effective distribution and reduced surrenders in key markets.
New business margin improved to 5.74%, with over 73% of new production carrying no guarantees, emphasizing ongoing underwriting discipline.
Continued investment in automation and digitalization is poised to enhance efficiency and profitability in the P&C value chain.
Generali is committed to scaling successful initiatives across countries, leveraging machine learning and advanced analytics in claims processing.

View recap

Gambling.com Group Limited Ordinary Shares

GAMB Q3 2025

Reported: 2025-11-13

Gambling.com Group reported record third quarter results with a 21% year-over-year revenue increase and 3% growth in adjusted EBITDA, driven primarily by their rapidly expanding sports data services business.

Key takeaways

Revenue from the sports data services segment surged over 300% year-over-year, now constituting 25% of total revenue.
The marketing segment remained flat, impacted by less favorable search rankings; however, improvements in this area were noted late in October.
OpticOdds, the company’s enterprise solution, doubled its revenue year-over-year, reflecting a growing customer base and enhanced service offerings.
Recognition of excellence in marketing business with the EGR Affiliate of the Year Award for the third consecutive year highlights brand strength and market position.
The company expects sustained growth and investment potential in the sports data services sector while maintaining robust cash flow from its marketing business.

View recap

GRAIL, LLC

GRAL Q3 2025

Reported: 2025-11-13

GRAIL reported strong third-quarter performance, with a 39% increase in Gallery volume and a 29% increase in revenue year-over-year, reflecting robust uptake and strategic developments in key markets.

Key takeaways

Gallery tests are growing in adoption, with approximately 420,000 tests sold across over 16,000 healthcare providers.
Strategic collaboration announced with Samsung to commercialize Gallery in South Korea and other Asian markets, alongside a $110 million equity investment from Samsung.
Successfully launched Gallery in Canada through a partnership with MedCan, expanding market presence.
Completed a $325 million private placement to strengthen financial position as the company progresses towards key milestones.
Positive results from PATHFINDER II study showcased substantial cancer detection improvements, underscoring Gallery’s effectiveness in early cancer diagnosis.

View recap

Global Water Resources, Inc.

GWRS Q3 2025

Reported: 2025-11-13

Global Water Resources, Inc. delivered solid third-quarter results with a 6.6% increase in total active service connections, bolstered by strategic acquisitions and favorable legislative changes that enhance long-term growth prospects.

Key takeaways

Completed the acquisition of seven Tucson water systems, adding approximately 2,200 connections and a rate base of $7.7 million.
New Arizona water legislation expected to enhance growth prospects by improving groundwater supply.
Active service connections reached 68,130, with a 3.3% annual growth rate excluding recent acquisitions.
Year-to-date capital investments totaled $49.6 million, focused on infrastructure improvements for existing utilities.
Anticipating a fair outcome in the ongoing rate case, with new rates needed to address rising costs and support earnings growth.

View recap

Hapag-Lloyd Aktiengesellschaft

HLAG.DE Q3 2025

Reported: 2025-11-13

Hapag-Lloyd reported solid volume growth and sequential earnings improvement in Q3 2025, although year-to-date performance remains below last year, primarily due to weaker freight rates.

Key takeaways

Q3 EBIT improved sequentially to USD 228 million, despite lower year-on-year earnings affected by softer overall freight rates.
Revenue for the first nine months rose 5%, underpinned by a 9% volume increase, significantly outperforming the market.
Cost discipline initiatives and the implementation of the Gemini East West network are enhancing operational efficiency and competitiveness.
The company is investing in up to 22 new ships to modernize its fleet and support its decarbonization efforts while improving operational costs.
Strong customer feedback is reflected in an all-time high Net Promoter Score, indicating positive reception of service quality and reliability.

View recap

Hyliion Holdings Corp.

HYLN Q3 2025

Reported: 2025-11-13

Hyliion Holdings demonstrated significant advancements in the KARNO Power Module during Q3 2025, exceeding key performance metrics and achieving critical regulatory milestones that enhance its market positioning.

Key takeaways

The KARNO Power Module achieved over 200 kilowatts of mechanical power, with electrical output expected to reach 200 kilowatts as commercialization approaches.
Successful internal testing confirmed compliance with California's stringent air quality standards, significantly easing regulatory hurdles for deployment.
The module completed over 100 days of operational testing with no unplanned downtime, showcasing its reliability across multiple load conditions.
UL certification is progressing well, with the design demonstrating full compliance on the first attempt, instilling confidence in product quality.
KARNO's flexibility to operate on over 20 fuel types, including natural gas and hydrogen, positions it favorably for diverse energy markets.

View recap

i-80 Gold Corp.

IAU.TO Q3 2025

Reported: 2025-11-13

i-80 Gold continues to execute its development plan effectively in Q3 2025, with strong advancements at Granite Creek and the commencement of construction at Archimedes, positioning the company for increased gold production.

Key takeaways

Granite Creek's ramp-up shows improved gold grades, with mining operations yielding 7,400 ounces sold during the quarter.
Construction at Archimedes has begun, marking progress toward developing a second underground mine, following successful performance at Granite Creek.
Improved groundwater management initiatives are on track, including the commissioning of a new pumping system and plans for a water treatment plant expected by Q1 2026.
Ongoing drilling programs at Granite Creek's South Pacific Zone reveal robust high-grade mineralization, supporting potential resource expansion.
The company's net asset valuation from five gold projects could reach approximately $5 billion at a gold price of $3,000, emphasizing substantial upside potential for investors.

View recap

i-80 Gold Corp.

IAUX Q3 2025

Reported: 2025-11-13

i-80 Gold achieved a significant operational turnaround in Q3 2025, with escalating gold production and robust advancements on key development projects. The company is en route to meet its consolidated guidance and is making progress on its ambitious multi-project strategy in Nevada.

Key takeaways

Granite Creek reported a turnaround from a loss to a small profit, with mining operations ramping up effectively and consistent reconciliation with geological models.
Successful drilling in the South Pacific Zone has revealed high-grade mineralization, with standout assay results potentially expanding resource estimates.
Construction commenced at Archimedes, marking a critical development milestone as the company advances its portfolio expansion.
The implementation of enhanced water management systems has improved control over groundwater, crucial for operational stability as mining activities increase.
i-80 Gold is on track to secure financing by mid-2026 to support ongoing and future project phases, aiming to realize significant net asset valuations from its five gold projects.

View recap

Ibotta, Inc.

IBTA Q3 2025

Reported: 2025-11-13

Ibotta, Inc. reported strong Q3 2025 results with revenue in the upper half of guidance and adjusted EBITDA exceeding expectations, indicating resilience despite challenging macroeconomic conditions.

Key takeaways

Q3 revenue was in the upper half of guidance while adjusted EBITDA significantly surpassed the top-end expectations.
The company has successfully implemented a full-service performance marketing platform for the CPG industry, emphasizing automation and scalability for 2026.
Strategic partnerships, including one with Surcana for independent media measurement, have been established to enhance campaign effectiveness for clients.
New product LiveLift received positive initial feedback, aimed at driving incremental sales and improving measurement dynamics for clients.
Despite market challenges, Ibotta is positioning itself as a vital partner for CPG brands, emphasizing ROI and performance-based media solutions.

View recap

Immuneering Corporation Class A Common Stock

IMRX Q3 2025

Reported: 2025-11-13

Immuneering Corporation delivered a compelling third quarter of 2025 highlighted by promising clinical results from its Phase 2a trial of atebimetinib in combination with FOLFIRINOX for pancreatic cancer patients.

Key takeaways

Reported significant overall survival improvements in first-line pancreatic cancer patients treated with atebimetinib and FOLFIRINOX, strengthening development pipeline.
A case study showcased a 71-year-old patient achieving a 100% reduction in liver lesions after five months of treatment, indicating strong efficacy and safety profile.
Company plans to share substantial data updates in 2026, with potential presence at major medical meetings.
Ongoing trials aim to enhance treatment options for pancreatic cancer, which remains a significant area of unmet medical need.

View recap

Aurora Mobile Limited

JG Q3 2025

Reported: 2025-11-13

Aurora Mobile achieved significant growth in Q3 2025, recording its second consecutive quarterly GAAP profit, driven by robust revenue growth across key segments.

Key takeaways

Q3 revenue reached RMB 19.9 million, marking a 15% year-over-year and 1% sequential increase, exceeding guidance.
Engagement app's Annual Recurring Revenue (ARR) grew by 160% year-over-year, reaching RMB 53.7 million, supported by a surge in customer adoption.
Financial risk management business revenue hit a record RMB 222.6 million, showing a 43% year-over-year growth.
Gross profit grew 20% year-over-year, achieving the highest growth in fifteen quarters, with improved gross margins.
Positive net operating cash inflow of RMB 23.3 million, the highest since 2020, reflecting strong financial stability.

View recap

Jumia Technologies AG

JMIA Q3 2025

Reported: 2025-11-13

Jumia's third-quarter 2025 results reflected strong momentum with a 25% revenue increase driven by accelerated customer demand and improved operational efficiency, positioning the company for sustainable growth.

Key takeaways

Physical goods GMV grew by 26% year-over-year, accelerating growth in core product categories.
Active customers rose 22%, marking the largest annual increase in three years, with enhanced customer loyalty indicated by a higher NPS score.
Adjusted EBITDA loss improved to $14 million, demonstrating effective cost management and operational leverage.
Continued focus on profitability with strategic investments in logistics and technology aimed at achieving full-year profitability by 2027.
Strong early fourth-quarter trends show over 30% year-over-year growth in orders and GMV, underscoring sustained demand.

View recap

KBC Group NV

KBC.BR Q3 2025

Reported: 2025-11-13

KBC Group delivered a robust Q3 2025 performance, reporting a net result of EUR 1.02 billion, supported by strong loan growth and balanced income sources. The guidance for 2025 income has been upgraded, reflecting solid operational momentum.

Key takeaways

Net interest income grew by 1% quarter-over-quarter and 10% year-over-year, driven by strong loan growth of 8% year-to-date.
Increased guidance for total income raised from EUR 5.85 billion to at least EUR 5.95 billion, with a target cost growth capped at 2.5%.
Strong solvency position at 14.9% and low credit cost ratio of 12 basis points demonstrates financial stability.
Launch of Kate 2.0, utilizing large language models, aims to enhance customer service autonomy and efficiency.
Interim dividend of EUR 1 per share paid on November 7 signals ongoing shareholder value commitment.

View recap

Loblaw Companies Limited

L.TO Q3 2025

Reported: 2025-11-13

Loblaw Companies Limited reported a strong third quarter, with revenue growing 4.6% to $19.4 billion and adjusted EBITDA increasing 7.2%, reflecting ongoing operational excellence and a robust store expansion strategy.

Key takeaways

Adjusted diluted net earnings per share rose 11.3% to $0.69, indicating strong profitability.
Same-store sales in food retail grew by 2%, outperforming the overall growth of 4.8% due to 76 new store openings.
Online sales increased by 18%, with delivery driving significant growth in the grocery channel.
The drug retail segment delivered 4% same-store sales growth, bolstered by a 5.9% rise in pharmacy sales.
Free cash flow from the Retail segment reached $325 million, underscoring strong operational cash generation.

View recap

L Brands, Inc.

LB Q3 2025

Reported: 2025-11-13

LandBridge reported robust Q3 2025 earnings, achieving a 7% sequential revenue growth and a remarkable 79% year-over-year increase in adjusted EBITDA, driven by diverse revenue streams and strategic land acquisitions.

Key takeaways

Total revenue reached $50.8 million, with significant contributions from oil and gas royalties and resource sales.
Adjusted EBITDA was $44.9 million, reflecting an impressive margin of 88% and underscoring operational efficiency.
Strategic land acquisitions, including 37,500 acres, are expected to add approximately $20 million in EBITDA starting 2026.
The company declared a quarterly dividend of $0.10 per share, with total liquidity of $108.3 million supporting ongoing growth initiatives.
Consistent performance leads to reaffirmed full-year 2025 guidance of $165 million to $175 million in adjusted EBITDA.

View recap

Lument Finance Trust, Inc.

LFT Q3 2025

Reported: 2025-11-13

Lument Finance Trust reported a modest Q3 2025 with net income of $0.01 per share and distributable earnings of $0.02, reflecting ongoing strategic adjustments amid a challenging economic landscape.

Key takeaways

Net interest income declined to $5.1 million, down from $7 million in Q2, primarily due to reduced portfolio size from loan repayments.
Maintained a conservative liquidity posture, holding ample unrestricted cash and entering a $450 million repurchase agreement with JPMorgan to enhance financing flexibility.
Focused on active asset management and resolving legacy positions as part of a disciplined capital redeployment strategy towards middle-market multifamily lending.
Strong multifamily sector fundamentals persist with steady occupancy rates and slowing new supply, supporting long-term demand and potential rent recovery.
Year-to-date issuance in the CRE CLO market exceeds $25 billion, indicating a favorable outlook for future securitization opportunities for Lument Finance Trust.

View recap

Lantern Pharma Inc.

LTRN Q3 2025

Reported: 2025-11-13

Lantern Pharma achieved significant clinical and regulatory milestones in Q3 2025, particularly with the successful Phase Ia trial of LP-184, which demonstrated a 48% clinical benefit rate in evaluable cancer patients.

Key takeaways

LP-184's Phase Ia trial met all primary endpoints, with notable tumor reductions in patients with specific DNA damage repair mutations.
Starlight Therapeutics received favorable guidance from the FDA for its planned pediatric CNS cancer trial, combining LP-184 with spironolactone.
Preliminary Phase II data from the LP-300 HARMONIC trial was presented, with a comprehensive update expected in December.
Lantern is advancing LP-184 into targeted Phase Ib/II trials across four significant oncology indications, with a potential market exceeding $7 billion.
The RADR AI platform demonstrated commercial readiness, with viable modules for licensing to biopharma partners.

View recap

Lulu's Fashion Lounge Holdings Inc. Common Stock

LVLU Q3 2025

Reported: 2025-11-13

Lulu's Fashion Lounge Holdings reported strong Q3 2025 results, driven by robust performance in special occasion categories and a significant improvement in gross and product margins, leading to a second consecutive quarter of positive adjusted EBITDA.

Key takeaways

Special occasion and bridesmaids categories generated substantial year-over-year net sales growth, reinforcing the company’s event attire strategy.
Product margins increased by approximately 500 basis points compared to the previous year, highlighting effective margin recovery initiatives.
Gross margins expanded to 42.6%, reflecting ongoing efforts to optimize product offerings and reduce markdowns.
Continued improvement in return rates signals enhanced customer satisfaction and demand for curated assortments.
A new credit agreement with White Oak enhances liquidity and financial flexibility, positioning Lulu's for sustained growth.

View recap

Manulife Financial Corporation

MFC.TO Q3 2025

Reported: 2025-11-13

Manulife Financial Corporation reported strong third quarter 2025 results, marked by robust earnings growth and a refreshed growth strategy emphasizing increased market presence and technological advancement.

Key takeaways

Core EPS increased by 16% year-over-year, driven by record core earnings across the Asia, Global WAM, and Canada segments.
New business CSM growth exceeded 15% across all insurance segments, indicating strong future earnings potential.
The company expects to achieve its 2027 core ROE target of over 18%, with a third quarter ROE of 18.1%.
The LICAT ratio remains strong at 138%, contributing to increased book value per share, which grew by 7% year-over-year.
A joint venture with Mahindra to enter the India insurance market highlights Manulife's commitment to expanding its footprint in Asia.

View recap

M-tron Industries, Inc.

MPTI Q3 2025

Reported: 2025-11-13

M-tron delivered solid Q3 2025 results with revenue growth driven by aerospace and defense sectors, although net income and gross margins saw declines due to tax adjustments and product mix shifts.

Key takeaways

Q3 revenues rose 7.2% YoY to $14.2 million, reflecting strong demand in avionics and space products.
Gross margins decreased to 44.3% from 47.8% in Q3 2024, primarily impacted by product mix and higher tariff costs.
Backlog surged 48% year-over-year to $58.8 million, highlighting robust demand and new program launches, particularly in defense.
Net income fell to $1.8 million ($0.63 per share), influenced by a $1 million tax-related expense and increased operating costs.
Continued focus on innovation with new internally compensated oscillators, driving growth in advanced product demand.

View recap

MicroVision, Inc.

MVIS Q3 2025

Reported: 2025-11-13

MicroVision showcased strong progress in Q3 2025 with the introduction of its innovative MOVIA S solid-state lidar sensor and the strategic acquisition of Scantinel Photonics, paving the way for enhanced product offerings and market expansion.

Key takeaways

Launched MOVIA S, an ultra-wide field of view solid-state sensor, set to significantly lower lidar costs and accelerate mass adoption in automotive and industrial sectors.
Announced acquisition of Scantinel Photonics, enhancing MicroVision's product portfolio with ultra-long-range lidar technology.
Positioned to integrate lidar with advanced software for improved performance and cost efficiency in various applications, including automotive safety and assistance systems.
Production of MOVIA S anticipated to commence in Q4 2026, with ongoing customer demonstrations showcasing strong interest.

View recap

NICE Ltd.

NICE Q3 2025

Reported: 2025-11-13

NICE delivered a robust Q3 2025 performance with total revenue reaching $732 million, driven by a 13% increase in cloud revenue to $563 million, fueled by strong demand for AI-driven solutions.

Key takeaways

Cloud revenue growth propelled by AI offerings, with annual recurring revenue (ARR) for self-service solutions accelerating to 49%.
Q3 bookings for AI solutions more than tripled, reinforcing customer demand for AI-powered CX transformations.
15% year-over-year increase in cloud backlog highlights the effectiveness of the AI-first strategy.
Significant deals include an 8-figure ACV contract with a leading global auto manufacturer, showcasing the value of unified cloud and AI platforms.
Successful integration of NICE Cognigy is enhancing growth opportunities and driving engagement-based AI capabilities across enterprise segments.

View recap

Nuveen Intermediate Duration Quality Municipal Term Fund

NIQ Q3 2025

Reported: 2025-11-13

NIQ reported strong Q3 2025 results with 5.8% organic revenue growth and significant improvements in profitability, raising full-year outlook due to ongoing momentum and successful transformation efforts.

Key takeaways

Organic constant currency revenue growth of 5.8%, with significant contributions from EMEA and Americas.
Adjusted EBITDA grew 25% to $223.7 million, with margins expanding 300 basis points to 21%.
Levered free cash flow reached $224 million, achieving most of 2025's cash flow guidance in Q3 alone.
Continued strong adoption of AI-driven omnichannel measurement products, enhancing client insights and revenue growth.
Integration of recent acquisitions progressing well, focusing on market penetration and business conversion.

View recap

North American Construction Group Ltd.

NOA.TO Q3 2025

Reported: 2025-11-13

North American Construction Group delivered strong Q3 results, posting $390 million in revenue and $99 million in EBITDA, reflecting effective operational execution and demand in both Canada and Australia.

Key takeaways

Q3 revenue increased 6% sequentially, with Australian revenue up 12% compared to Q2 and 26% year-over-year.
Gross profit margin improved to 14.6%, aided by reduced reliance on external maintenance and steady operational performance.
Free cash flow reached $46 million, supporting growth capital and shareholder returns while maintaining a net debt level of $904 million.

View recap

NextPlat Corp Common Stock

NXPL Q3 2025

Reported: 2025-11-13

NextPlat Corp's Q3 2025 earnings reflect ongoing operational challenges, but improvements in revenue and cost management signal a positive trajectory moving into 2026.

Key takeaways

Introduction of successful business development initiatives has started to yield significant revenue and profitability improvements, particularly in the Healthcare segment.
E-commerce and communications segments saw robust sales, particularly in satellite-based connectivity products and high-margin recurring revenues.
Optimism around the 340B business line, which has shown a strong rebound and improved customer engagement in recent months.
Payroll savings of approximately $200,000 monthly achieved through headcount reductions, indicating ongoing cost management efforts.
Strategic leadership changes, including a new CFO and VP of Healthcare Operations, aimed at enhancing operational effectiveness.

View recap

Nexus Industrial REIT

NXR-UN.TO Q3 2025

Reported: 2025-11-13

Nexus Industrial REIT delivered strong third-quarter results with robust leasing activity and significant new developments, solidifying its position as a pure-play industrial REIT.

Key takeaways

Completed 440,000 square feet of new industrial development, expected to generate $6.6 million in annual stabilized NOI with an attractive 9.4% unlevered return.
Achieved a 2.9% increase in same-property NOI during the quarter driven by strong organic growth and averaging 60% leasing spreads on renewals.
Successfully signed a 15-year lease for a 223,000 square foot property with one of Canada’s largest construction firms, enhancing the quality of the tenant base.
Industrial occupancy rose to 96%, reinforcing demand and operational efficiency across the portfolio.

View recap

Orezone Gold Corporation

ORE.TO Q3 2025

Reported: 2025-11-13

Orezone's Q3 2025 performance reflected strong operational positioning despite lower gold production, with the company on track to meet its 2025 guidance of 115,000 to 130,000 ounces. The successful completion of the Stage 1 hard rock expansion brings an optimistic outlook for production growth.

Key takeaways

Gold production for Q3 totaled 23,371 ounces, with revenue of $68.9 million driven by an average realized price of $3,375 per ounce.
All-in sustaining costs increased to $1,958 per ounce, influenced by external factors including currency strength and delayed gold sales due to weather.
Cash and bullion on the balance sheet reached $104.2 million, supported by strong Q4 production forecasts and a successful CapEx management.
The new hard rock plant is on schedule for early December startup, expected to boost production capacity by approximately 45% in 2026.
Revised all-in sustaining costs guidance for 2025 now ranges between $1,700 and $1,800, reflecting increased government royalties and external cost pressures.

View recap

OTC Markets Group Inc.

OTCM Q3 2025

Reported: 2025-11-13

OTC Markets Group reported a robust performance in Q3 2025, with gross and net revenues increasing by 15%, signaling strong growth across all business lines.

Key takeaways

Continued strong revenue growth driven by OTC Link (up 23%) and Market Data (up 15%).
Corporate Services achieved its second consecutive quarter of revenue growth, propelled by OTCID Basic Market sales.
Momentum for the Overnight Trading initiative is building, with increased engagement from broker-dealer subscribers following market improvements in South Korea.
OTCID Market has quickly garnered traction since its launch, enhancing disclosure for corporate clients and differentiating from lower-quality Pink Limited securities.
Enhanced customer platform, OTCIQ.com, launched to improve client experience, further integrating data sources for streamlined compliance.

View recap

PAN AMERICAN SILVER CORP

PAAS Q3 2025

Reported: 2025-11-13

Pan American Silver reported exceptionally strong Q3 2025 results, driven by rising metal prices and operational efficiencies, achieving record free cash flow of $251.7 million.

Key takeaways

Record attributable revenue of $884.4 million, with net earnings of $169.2 million, or $0.45 per share.
Successful integration of MAG Silver, with early benefits seen in reduced costs and improved margins.
Attributable silver production of 5.5 million ounces; production guidance raised to 22-22.5 million ounces for the year.
Strategic dividend increase to $0.14 per share, reflecting robust cash flow and strong liquidity position of $1.7 billion.
Continued exploration success at La Colorada with significant resource expansion, potentially enhancing future production capabilities.

View recap

PLBY Group, Inc.

PLBY Q3 2025

Reported: 2025-11-13

No summary provided.

Key takeaways

Revenue reached $29 million, with net income at $500,000 and adjusted EBITDA of $4.1 million, despite litigation expenses.
Licensing revenue surged 61% year over year, bolstered by six new licensing deals, totaling 14 for the year.
Honey Birdette's comparable store sales rose by 22%, with gross margins improving by 700 basis points to 61%.
Playboy is refocusing on brand content, aiming to leverage media, licensing, and experiential growth with minimal investment.
The relaunch of Playboy magazine and new unique subscription offerings are expected to enhance brand engagement and revenue streams moving forward.

View recap

Planet 13 Holdings Inc.

PLNH Q3 2025

Reported: 2025-11-13

Planet 13 reported a challenging Q3 2025 with revenues of $23.3 million, down from $26.6 million in Q2, largely driven by a decline in tourism and operational adjustments. However, initial signs of recovery in October offer encouragement for improved performance in Q4.

Key takeaways

SuperStore revenue declined to $9.8 million amid a 10% drop in tourism impacting Las Vegas operations.
Neighborhood store network revenue reached $11.3 million, with Florida recognized as reaching a low point due to quality issues, but showing signs of recovery.
Adjusted EBITDA loss of $4.1 million reflects significant one-time charges, while gross margin was impacted by strategic pricing and inventory clearances.
Cash reserves remain solid at $17.2 million, with minimal capital expenditures expected for the remainder of the year.
Planned exit from California operations is set to be completed in Q1 2026, allowing for a stronger focus on high-return markets.

View recap

Protalix BioTherapeutics, Inc.

PLX Q3 2025

Reported: 2025-11-13

Protalix BioTherapeutics reported strong year-to-date revenue growth of 24%, though third-quarter revenues showed a slight decline of 1% compared to the previous year, reflecting ongoing inventory management by key partners.

Key takeaways

Total revenues for the first nine months of 2025 reached $46.4 million, marking a 24% year-over-year increase.
Third-quarter revenue was $17.9 million, down 1% year-over-year due to variable inventory control by partners.
The company is advancing its PRX-115 candidate for the treatment of uncontrolled gout, having filed for a Phase 2 clinical trial.
Research and development expenses surged by 58% for the first nine months, emphasizing continued investment in pipeline projects.
Protalix maintains a strong cash position and positive net income, supporting its strategic focus on commercial success and innovation.

View recap

Persimmon Plc

PSN.L Q3 2025

Reported: 2025-11-13

Persimmon Plc reported solid performance in Q3, maintaining robust forward sales and pricing amid a challenging market environment, while continuing to invest in growth initiatives.

Key takeaways

Forward sales increased by approximately 15%, demonstrating resilience despite industry softening.
Pricing remains robust, with average selling prices up 1.5% year-over-year, supported by strategic land acquisitions and disciplined incentives between 4%-5%.
The company plans to open around 100 new outlets next year, contingent on securing planning approvals, reflecting strong growth ambitions.
Customer sentiment is stabilizing after a mid-year decline, with positive momentum noted in recent weeks.
Launch of Rezide product shows initial traction with one sale, reinforcing Persimmon's commitment to providing diverse customer options in a competitive market.

View recap

Poste Italiane SpA

PST.MI Q3 2025

Reported: 2025-11-13

Poste Italiane achieved record results in Q3 and the first nine months of 2025, with revenues up 4% to EUR 9.6 billion and net profit increasing 11% to EUR 1.8 billion, driven by strong performance across all business segments.

Key takeaways

Adjusted EBIT rose by 10% to EUR 2.5 billion year-to-date, highlighting effective cost management and revenue growth.
Successful migration to the Super App now includes 15 million users, reflecting strong digital adoption within the customer base.
Record interim dividend of EUR 0.40 per share to be paid in November, representing a 21% increase from the previous year.
Introduction of TIM Energia in collaboration with TIM marks a key strategic initiative aimed at enhancing service offerings and customer reach.
Solid balance sheet with a Solvency II ratio of 312%, providing financial flexibility for future growth initiatives.

View recap

Channel Therapeutics Corporation

PTHS Q3 2025

Reported: 2025-11-13

Pelthos Therapeutics reports strong third-quarter results, highlighted by the successful launch of ZELSUVMI and significant investor backing, positioning the company for future growth in the pediatric topical treatment market.

Key takeaways

Generated $7.1 million in net product revenue primarily from strong demand for ZELSUVMI, the first FDA-approved at-home treatment for molluscum contagiosum.
Completed a $50 million PIPE financing to support ZELSUVMI's launch and a subsequent $18 million convertible notes financing for the acquisition of Xepi.
Expect cash flow breakeven from operations before the end of 2026, driven by ZELSUVMI's growth.
Sales force expansion planned with the addition of 14 representatives to enhance market coverage and accelerate sales growth.
The market for molluscum contagiosum presents substantial opportunity with an estimated 6 million new cases annually in the U.S.

View recap

Vicarious Surgical Inc. Class A Common Stock

RBOT Q3 2025

Reported: 2025-11-13

Vicarious Surgical reported a significant 35% reduction in operating expenses in Q3 2025, leading to a narrowed net loss compared to the same period last year, as the company focuses on achieving design freeze for its surgical system by year-end 2026.

Key takeaways

Total operating expenses decreased to $11.5 million, down from $17.8 million in Q3 2024.
GAAP net loss narrowed to $11.1 million ($1.86 per share) from $17.1 million ($2.90 per share) year-over-year.
Successful fundraising added approximately $5.2 million in net proceeds, bolstering the balance sheet as cash burn reduction efforts are emphasized.
Management is implementing targeted outsourcing to improve capital efficiency while preserving innovation in critical technology areas.

View recap

RWE Aktiengesellschaft

RWE.DE Q3 2025

Reported: 2025-11-13

RWE AG demonstrated robust financial performance in the first nine months of 2025, achieving over 80% of its full-year adjusted earnings per share target, bolstered by strategic asset sales and strong project progress.

Key takeaways

Adjusted EBITDA for the first nine months stood at EUR 3.5 billion, influenced by normalized prices and weak wind conditions.
Significant non-recurring gain of EUR 225 million from the sale of a data center development project enhances the Flexible Generation segment’s results.
RWE is progressing with 11.4 gigawatts of capacity under construction, with over 2 gigawatts expected to start operations by year-end.
A new partnership with Apollo Global Management provides EUR 3.2 billion for a 25.1% stake in Amprion, improving the balance sheet and ensuring future growth.
The company confirmed its dividend target of EUR 1.2 per share for fiscal year 2025 amid a successful share buyback program.

View recap

SMA Solar Technology AG

S92.DE Q3 2025

Reported: 2025-11-13

The company experienced a challenging third quarter with lower-than-expected sales impacting guidance for 2025, despite continued growth in the large-scale project solutions segment and strategic restructuring.

Key takeaways

Revenues for the home business segment are expected to decline significantly in 2025 due to macroeconomic pressures, resulting in a revised sales guidance of EUR 1.45 million to EUR 1.5 million.
The large-scale solutions division remains robust, with anticipated sales slightly above the previous year’s performance, driven by increased demand for grid stability solutions.
The company plans to reduce its workforce by approximately 350 FTEs in Germany and non-core markets while growing its teams in Poland and India to enhance operational efficiency.
EBITDA and EBIT are forecasted to be negatively impacted by lower sales and significant one-off costs totaling between EUR 250 million and EUR 265 million for the year.
Strategic initiatives include the successful launch of innovative energy solutions, such as the first utility-scale battery energy storage system in continental Europe, asserting the company's position as a leader in the renewable energy sector.

View recap

Sally Beauty Holdings, Inc.

SBH Q4 2025

Reported: 2025-11-13

Sally Beauty Holdings achieved strong fourth-quarter results, with a 1.3% rise in comparable sales and elevated margins, while delivering a solid 12% increase in adjusted diluted earnings per share for the fiscal year 2025.

Key takeaways

Fourth-quarter gross margin expanded by 100 basis points to 52.2%, complemented by an adjusted operating margin of 9.4%.
Full-year revenue reached $3.7 billion, with adjusted diluted earnings per share growing to $1.90, up 12% year-over-year.
Successful initiatives included maintaining a leadership position in color, launching the Sally Ignited brand refresh, and generating $46 million in incremental benefits from the Fuel for Growth program.
Significant investments in digital channels and customer-centric strategies are poised to unlock further growth opportunities in fiscal 2026.
Strong cash flow from operations of $275 million enabled strategic debt reduction and shareholder value through $50 million in share repurchases.

View recap

Stellus Capital Investment Corporation

SCM Q3 2025

Reported: 2025-11-13

Stellus Capital Investment Corporation reported a mixed third quarter for FY2025, with GAAP net investment income of $0.32 per share, alongside a decline in net asset value driven by dividend payments exceeding earnings.

Key takeaways

Generated $0.32 per share of GAAP net investment income and core net investment income of $0.34 per share, adjusted for excise taxes.
Net asset value per share fell by $0.16, primarily due to $0.08 in dividends exceeding earnings and unrealized losses from two debt investments.
Portfolio valuation increased to over $1 billion, reflecting investments of $51.3 million in five new companies during the quarter.
Maintained strong asset quality with 82% of the portfolio rated positively and no additions to the nonaccrual list.
Successfully issued approximately 531,000 shares for $7.4 million under the ATM program, reinforcing capital position while all issuances were above net asset value.

View recap

Serve Robotics Inc.

SERV Q3 2025

Reported: 2025-11-13

Serve Robotics achieved substantial growth in Q3 2025, deploying over 1,000 autonomous delivery robots and significantly expanding its market reach, highlighted by a 66% increase in delivery volume.

Key takeaways

Delivery reliability approached 100%, reflecting operational excellence as volume soared.
Expanded restaurant partnerships to over 3,600, a 45% quarterly increase and a ninefold rise year-over-year.
Fleet size grew tenfold and market coverage expanded to five operational hubs, reaching over 3 million people.
Strategic partnerships with DoorDash and Uber enhance delivery capacity and efficiency, optimizing robot utilization.
New market expansions set for Buckhead, Fort Lauderdale, and Alexandria by year-end, further solidifying national presence.

View recap

Seanergy Maritime Holdings Corp.

SHIP Q3 2025

Reported: 2025-11-13

Seanergy Maritime Holdings Corp reported a profitable Q3 2025, driven by strong earnings from its Capesize and Newcastlemax fleet, with net revenue of $47 million and a declared cash dividend of $0.13 per share.

Key takeaways

Q3 net revenue rose 6% YoY to $47 million; adjusted EBITDA was $27.5 million, highlighting consistent operational performance.
Declared total cash dividends of $0.23 per share for 2025, reflecting a commitment to shareholder returns despite market volatility.
Successful fleet optimization with the sale of a vintage Capesize vessel for $21.6 million, enhancing liquidity and fleet composition.
Strategic newbuilding order for a 181,000 DWT Capesize at a competitive price of $75 million, scheduled for delivery in 2027, positioning for future market growth.
Strong cash position of $37 million, enabling continued investment in fleet and maintaining robust financial flexibility.

View recap

SKYX Platforms Corp. Common Stock

SKYX Q3 2025

Reported: 2025-11-13

SKYX Platforms Corp. reported record revenue of $24 million in Q3 2025, reflecting consistent growth for seven consecutive quarters, bolstered by strategic partnerships and an expanding product line.

Key takeaways

Revenue increased by $1 million from Q2 2025, demonstrating sustained market penetration.
Strategic agreements with Global Ventures Group for smart home technology deployments across Middle Eastern projects signify significant international expansion opportunities.
Launch of a new AI-driven e-commerce platform expected to enhance sales conversion rates by 30%.
Completed a $5 million capital raise from leading shareholders, restructured existing notes to extend maturity to 2030, reflecting strong investor confidence.
Anticipating further revenue growth through the introduction of new product lines, including advanced smart heating solutions and ceiling fans.

View recap

Suburban Propane Partners, L.P.

SPH Q4 2025

Reported: 2025-11-13

Suburban Propane Partners delivered strong fiscal 2025 results with nearly 6% growth in propane volumes and an 11.2% increase in adjusted EBITDA, driven by effective margin management and strategic acquisitions.

Key takeaways

Propane volumes increased nearly 6% year-over-year, bolstered by normal winter weather and post-hurricane demand.
Adjusted EBITDA rose by $28 million, reflecting successful margin management in a rising commodity price environment.
The company completed acquisitions totaling approximately $77 million, expanding its market presence in New Mexico, Arizona, and California.
Launched an at-the-market equity program, raising $23.5 million to support growth initiatives and debt reduction.
Improved leverage ratio to 4.29 times, a solid reduction from 4.76 times in the previous year, enhancing financial stability.

View recap

Stratasys Ltd.

SSYS Q3 2025

Reported: 2025-11-13

Stratasys Ltd. reported solid operating cash flow and earnings per share in Q3 2025, showcasing the resilience of its business model amidst macroeconomic challenges. Continued focus on operational excellence and customer engagement drives growth in high-value verticals, particularly in aerospace, defense, and medical devices.

Key takeaways

Strong year-over-year increase in hardware sales, with notable gains in aerospace and defense sectors, including purchases from Boeing and Honeywell.
Successful demonstration of advanced manufacturing capabilities during the U.S. Navy’s Trident Warrior 25 exercise, highlighting operational resilience and logistics efficiency.
Strategic adoption of the H350 platform by a major pharmaceutical company signals potential growth in medical device and drug development applications.
Expansion of customer partnerships in high-tech sectors, including a significant investment by a leading U.S. technology firm in Stratasys' F3300 systems for prototyping and production.
The commitment to sustainability and localized manufacturing remains central to the company’s long-term growth strategy, aligning with industry trends.

View recap

SLR Senior Investment Corp.

SUNS Q3 2025

Reported: 2025-11-13

Sunrise Realty Trust delivered strong third-quarter results, generating distributable earnings of $0.31 per share, comfortably covering its $0.30 dividend, while maintaining a conservative loan-to-cost ratio of 56%.

Key takeaways

Distributable earnings of $0.31 per share exceeded the dividend of $0.30, indicating solid financial health.
The company's conservative leverage at 0.4 times and a robust portfolio of predominantly floating-rate loans are poised for earnings growth as interest rates decline.
An uptick in financing requests signals improved market confidence and increased transaction volumes in the transitional commercial real estate sector, benefiting SUNS's acquisition strategy.
The active pipeline includes two signed nonbinding term sheets totaling approximately $170 million, showcasing ongoing commitment and market engagement.
Significant insider confidence, with continued share purchases from management, suggests strong belief in the company’s long-term value and growth potential.

View recap

Stran & Company Inc. Common Stock

SWAG Q3 2025

Reported: 2025-11-13

Stran & Company, Inc. reported strong Q3 results with a 29% year-over-year sales increase, reflecting robust demand and successful integration of acquisitions, while improving profitability metrics.

Key takeaways

Q3 sales reached $26 million, contributing to a 56.7% increase in total sales for the first nine months of 2025, totaling $87.3 million.
EBITDA improved by $2.8 million year-over-year, moving from a loss of $3.2 million to a loss of $384,000, demonstrating effective cost management.
The Stran Loyalty Solutions segment, bolstered by the Gander Group acquisition, generated $26.9 million in revenue, significantly up from $3.5 million the previous year.
Operating expenses grew by 30.3% year-over-year, while the percentage of operating expenses compared to sales decreased from 37.7% to 31.3%.
Continued share repurchase activity included the buyback of approximately 267,000 shares, supporting shareholder value amidst a strong cash position of $11 million.

View recap

Terna - Rete Elettrica Nazionale Societa per Azioni

TEZNY Q3 2025

Reported: 2025-11-13

Terna reported solid progress in its infrastructure development and regulatory framework, with strategic projects advancing and an interim dividend of €11.92 per share maintained for the 2025 fiscal year.

Key takeaways

Completed first submarine cable installation for the Tyrrhenian Link, enhancing Italy's transmission capacity.
Launched authorization processes for the Central and Sardinian Link projects, signaling commitment to renewable integration and grid robustness.
Secured 88% of the capital expenditure plan through effective procurement, maintaining project timelines and mitigating supply chain risks.
Board approved a flat interim dividend of €11.92 per share, aligning with the company's new dividend policy for the 2024-2028 business plan.
National electricity demand showed a slight contraction of 1.2%, while renewable sources continued to generate around 50% of production, emphasizing the shift towards greener energy.

View recap

Taseko Mines Limited

TGB Q3 2025

Reported: 2025-11-13

Taseko Mines reported a solid third quarter for 2025, showing improved operational performance and financial metrics, signaling a positive outlook for the remainder of the year.

Key takeaways

Copper production reached nearly 28 million pounds, benefiting from higher-grade ore and improved mill recoveries at 77%.
Adjusted EBITDA for the quarter was $62 million, reflecting operational efficiencies despite rising maintenance costs.
The Florence project is on track to commence copper production early next year, with significant milestones achieved in commissioning and regulatory approvals.
Increased wellfield performance is promising, with initial flow rates exceeding expectations and plans to expand drilling activities underway.
The recent equity offering has bolstered the balance sheet, allowing repayment of $75 million from the revolving credit facility and enhancing liquidity for growth initiatives.

View recap

Taseko Mines Limited

TKO.TO Q3 2025

Reported: 2025-11-13

Taseko Mines reported a robust third quarter in 2025 with improved copper and molybdenum production, driven by higher-grade ore and operational adjustments. The company is on track for a strong fourth quarter and anticipates significant advancements at the Florence project.

Key takeaways

Copper production reached nearly 28 million pounds, with a recovery rate improvement to 77%.
Molybdenum production surged to 560,000 pounds, reflecting the enhanced quality of mined grades.
Adjusted EBITDA for the quarter amounted to $62 million, bolstered by operational efficiencies and higher mineral grades.
The Florence project is progressing well, achieving substantial completion of the SX/EW plant and beginning initial copper production commissioning.
Taseko’s recent equity offering has strengthened its balance sheet, enabling repayment of $75 million in debt and enhancing working capital.

View recap

Tencent Music Entertainment Group

TME Q3 2025

Reported: 2025-11-13

Tencent Music Entertainment Group (TME) reported strong Q3 2025 results, driven by growth in its online music and concert segments, reflecting robust demand for diverse music offerings and live events.

Key takeaways

Continued expansion of content offerings, including partnerships with popular labels and game developers, spurring a surge in user engagement.
Significant growth in live concert revenue, highlighted by the successful hosting of G-Dragon’s world tour, attracting over 150,000 attendees.
Successful launch of new flagship concert IPs, including the TME Live International Music Awards, enhancing TME's reputation as a leader in live entertainment.
Strong performance in artist-centric initiatives, with notable releases achieving top rankings across music charts.
Commitment to ESG initiatives, engaging over 380,000 participants in music education programs, showcasing TME’s dedication to social responsibility.

View recap

Terna - Rete Elettrica Nazionale Societa per Azioni

TRN.MI Q3 2025

Reported: 2025-11-13

Terna reported solid progress in its 9-month 2025 results, supported by strategic infrastructure developments and increased procurement efficiency as the company advances towards its 2024-2028 Industrial Plan.

Key takeaways

Significant strides made in the Tyrrhenian Link project, nearing completion of the first submarine cable installation, with the project set to establish a new world record.
Strong procurement coverage with 88% of the 2024-2028 CapEx plan contracted, ensuring project continuity and risk mitigation.
Approved interim dividend of EUR 11.92 per share, maintaining the Board's commitment to stable shareholder returns amid a consistent regulatory environment.
Notable increase in national photovoltaic production by 23%, highlighting Terna's strategic positioning in Italy's renewable energy landscape.
Regulatory support confirmed through EUR 93 million in output-based incentives for enhanced transmission capacity and investment efficiency.

View recap

United States Antimony Corporation

UAMY Q3 2025

Reported: 2025-11-13

United States Antimony Corporation reported a significant 182% year-over-year increase in sales for the first nine months of 2025, driven by price rises and improved production, though the company also incurred a net loss reflecting certain non-cash expenses.

Key takeaways

Consolidated sales reached $26.2 million for the first nine months, with a gross margin up to 28%, despite facing pressure from declining antimony prices.
Positive cash flow was generated from operating activities, excluding working capital adjustments, indicating improved financial health compared to the previous year.
The company significantly bolstered its cash position, ending Q3 with $38.5 million, primarily from warrant exercises and shares sales.
Secured a three-year antimony ore supply agreement and two major five-year sales contracts, strengthening revenue and supply chains.
Expanded mining claims and processing capabilities, enhancing its position as a vertically integrated player in the critical minerals market.

View recap

Urgent.ly Inc. Common Stock

ULY Q3 2025

Reported: 2025-11-13

Urgent.ly Inc. achieved positive non-GAAP operating income for the third quarter of 2025, reflecting a significant turnaround amid steady revenue growth and improved gross margins.

Key takeaways

Q3 revenue of $32.9 million aligned with expectations, marking the eighth consecutive quarter of meeting revenue guidance.
Gross margin improved to 25%, a 13-point increase from Q3 2022, indicating ongoing operational efficiency.
Non-GAAP operating expenses decreased by 25% year-over-year, contributing to a pivotal shift towards profitability.
The company is on track for a productive renewal cycle with existing OEM and fleet partnerships, alongside new contracts in the insurance sector.
A significant partnership with Sony Honda Mobility is set to enhance Urgent.ly’s market positioning in the emerging EV segment.

View recap

Usio, Inc.

USIO Q3 2025

Reported: 2025-11-13

Usio delivered a strong third quarter in fiscal 2025, marked by record processing volumes and solid profits, positioning the company for a significant uptick in growth entering 2026.

Key takeaways

Achieved record overall transaction volume of 16.2 million, up 8% year-over-year, evidencing robust demand across services.
ACH business grew impressively by 30% year-over-year, contributing to improved margins and profitability.
Adjusted EBITDA remained positive at $368,000, with operating cash flow of $1.4 million, highlighting continued financial stability.
Significant progress in client implementations, with a growing pipeline that positions Usio well for future revenue growth.
Ongoing investments in new technology and products, including innovative payment solutions, reinforce strategic momentum heading into 2026.

View recap

Venus Concept Inc.

VERO Q3 2025

Reported: 2025-11-13

Venus Concept Inc. reported a high single-digit year-over-year decline in total revenue for Q3 2025, primarily due to softness in the hair restoration segment, although sales of energy-based devices showed 2% growth.

Key takeaways

Strong execution led to a 2% increase in sales of energy-based devices, particularly in key US markets.
The launch of the Venus Nova platform, designed to enhance non-invasive treatments, reflects the company's strategic R&D focus and targets significant market segments responding to GLP-1 medication trends.
Challenges with the pending sale of the Venus Hair business are ongoing, including delays due to counterparty issues and legal assistance sought for resolution.
Financial restructuring efforts included a $11.5 million debt-to-equity exchange, improving liquidity as the company prepares for future growth initiatives.
Anticipated sequential revenue growth in Q4 2025 supported by the limited commercial launch of Venus Nova in December.

View recap

Wienerberger AG

WIE.VI Q3 2025

Reported: 2025-11-13

Wienerberger's Q3 2025 results reflect stable performance amid a challenging residential housing market, with EBITDA remaining consistent year-over-year at €202 million.

Key takeaways

Revenue increased by 4% year-over-year to approximately €3.5 billion, driven by stable turnover in roofing and piping segments.
North America faced significant declines, with a 30% decrease in new residential housing activity in Ontario and a 10% decline in the U.S.
While the U.K. and Ireland experienced a drop in housing market activity, renovation and infrastructure projects supported overall performance in these regions.
Eastern Europe remains stable with a notable exception in Hungary, where government initiatives are expected to stimulate housing demand.
Wienerberger's focus on innovation enabled it to outperform the underlying market in ceramics and pipes, despite overall market challenges.

View recap

Worksport Ltd.

WKSP Q3 2025

Reported: 2025-11-13

Worksport Ltd. posted robust Q3 2025 results with net sales of $5 million, marking a 61% year-over-year increase. Despite an operating loss of $4.9 million, the company demonstrated significant margin expansion and a solid path toward profitability by 2026.

Key takeaways

Net sales grew 61% year over year, up from $3.1 million in Q3 2024, demonstrating strong market demand and effective channel expansion.
Gross margin improved significantly to 31.3%, attributed to enhanced operational efficiencies and a favorable product mix, setting a foundation for profitability.
Total indebtedness reduced to $2.9 million from $5.3 million at the end of 2024, strengthening the balance sheet and financial stability.
Operating expenses rose to $6.4 million, reflecting investments in growth and marketing associated with the AL4 product launch, but operating cash burn showed a slight increase to $4.3 million.
Continued investment in R&D is focused on scaling production of US-made tonneau covers, highlighting a strategic commitment to innovative product offerings.

View recap

Wrap Technologies, Inc.

WRAP Q3 2025

Reported: 2025-11-13

Wrap Technologies delivered a strong Q3 2025, reporting $2 million in gross revenue, a 12% increase from subscription sales, marking a significant step in its transition to a comprehensive nonlethal response solutions provider.

Key takeaways

The company's revenue growth highlights a strategic pivot from device manufacturing to subscription-based solutions for law enforcement.
The BolaWrap 150 achieved a remarkable 92% field success rate with zero fatalities, reflecting growing adoption and effectiveness in the field.
New subscription models for training and policy support are enhancing customer relationships and positioning Wrap for long-term profitability.
Recent product launches, including WrapVision and WrapReality, are expanding Wrap's ecosystem, promoting the transition to a high-margin recurring revenue model.
Wrap's commitment to integrating nonlethal responses with emerging technologies positions the company to capture significant market opportunities within the law enforcement sector.

View recap

Xunlei Limited

XNET Q3 2025

Reported: 2025-11-13

Xunlei Limited reported strong Q3 2025 results with total revenues of $126.4 million, a 57.7% year-over-year increase, bolstered by significant growth in subscription and live streaming services.

Key takeaways

Subscription revenue reached $40.7 million, marking a 22.3% increase year-over-year, driven by a rise in premium subscribers.
Live streaming services surged 127.1% year-over-year to $49.1 million, boosted by expanding international operations and strategic acquisitions.
Cloud computing revenues increased 44.9% year-over-year to $36.6 million, reflecting strong demand from enterprise customers.
A substantial gain of $545.8 million from the IPO of Arashi Vision Inc. significantly enhanced the company’s financial position and strategic flexibility.

View recap

Earnings Recaps

Aumann AG

Absci Corporation Common Stock

Alcon Inc.

Bayer Aktiengesellschaft

Better Home & Finance Holding Company Class A Common Stock

Bilibili Inc.

Bitfarms Ltd.

Bitfarms Ltd.

Bitcoin Depot Inc. Class A Common Stock

Broadwind, Inc.

Beyond Meat, Inc.

Crescent Capital BDC, Inc.

Central Puerto S.A.

Chemtrade Logistics Income Fund

CI&T Inc

Cellebrite DI Ltd. Ordinary Shares

ClearPoint Neuro, Inc.

Canadian Solar Inc.

CuriosityStream Inc.

CXApp Inc. Class A Common Stock

The Walt Disney Company

Dream Unlimited Corp.

Deutsche Telekom AG

Durr Aktiengesellschaft

Eagle Point Credit Company Inc.

Eagle Point Income Company Inc.

Fortress Biotech, Inc.

FLEX LNG Ltd.

Flutter Entertainment plc

Fly Leasing Limited

Fiera Capital Corporation

Fathom Holdings Inc.

Assicurazioni Generali S.p.A.

Gambling.com Group Limited Ordinary Shares

GRAIL, LLC

Global Water Resources, Inc.

Hapag-Lloyd Aktiengesellschaft

Hyliion Holdings Corp.

i-80 Gold Corp.

i-80 Gold Corp.

Ibotta, Inc.

Immuneering Corporation Class A Common Stock

Aurora Mobile Limited

Jumia Technologies AG

KBC Group NV

Loblaw Companies Limited

L Brands, Inc.

Lument Finance Trust, Inc.

Lantern Pharma Inc.

Lulu's Fashion Lounge Holdings Inc. Common Stock

Manulife Financial Corporation

M-tron Industries, Inc.

MicroVision, Inc.

NICE Ltd.

Nuveen Intermediate Duration Quality Municipal Term Fund

North American Construction Group Ltd.

NextPlat Corp Common Stock

Nexus Industrial REIT

Orezone Gold Corporation

OTC Markets Group Inc.

PAN AMERICAN SILVER CORP

PLBY Group, Inc.

Planet 13 Holdings Inc.

Protalix BioTherapeutics, Inc.

Persimmon Plc

Poste Italiane SpA

Channel Therapeutics Corporation

Vicarious Surgical Inc. Class A Common Stock

RWE Aktiengesellschaft

SMA Solar Technology AG

Sally Beauty Holdings, Inc.

Stellus Capital Investment Corporation

Serve Robotics Inc.

Seanergy Maritime Holdings Corp.

SKYX Platforms Corp. Common Stock

Suburban Propane Partners, L.P.

Stratasys Ltd.

SLR Senior Investment Corp.

Stran & Company Inc. Common Stock